Efficacy of Subcutaneous Bortezomib in the Management of Patients With Multiple Myeloma or Relapsed Mantle Cell Lymphoma

Clinical Medicine Insights: Therapeutics - New Zealand
doi 10.4137/cmt.s9308
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications


Related search